ADC Therapeutics Announces Updated LOTIS-2 Results Demonstrating Durable, Long-Term Responses of ZYNLONTA® in Relapsed/Refractory DLBCL
June 09, 2023 07:15 ET
|
ADC Therapeutics SA
LAUSANNE, Switzerland, June 09, 2023 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced updated results from LOTIS-2, the pivotal Phase 2 clinical trial of ZYNLONTA® (loncastuximab...
Vor Bio to Participate in the Goldman Sachs Healthcare Conference
June 05, 2023 08:00 ET
|
Vor Biopharma
CAMBRIDGE, Mass., June 05, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will present and host in-person 1x1 investor meetings at the Goldman...
Adaptive Biotechnologies Highlights New Data at ASCO 2023 and EHA 2023 Underscoring the clonoSEQ® Assay’s Impact as a Standard for Minimal Residual Disease Assessment in Patients with Hematologic Cancer
June 02, 2023 07:34 ET
|
Adaptive Biotechnologies
New data emphasizes the value of MRD testing in predicting survival outcomes and informing the personalized treatment of patients with hematologic cancers clonoSEQ continues to be the MRD test of...
The International Myeloma Foundation (IMF) Honors 2023 Research Achievement Awardees, Dr. Maria-Victoria Mateos and Dr. Thomas Martin
June 01, 2023 08:45 ET
|
International Myeloma Foundation
LOS ANGELES, June 01, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) is proud to announce the recipients of this year’s Robert A. Kyle Achievement Award and Brian G.M. Durie...
ADC Therapeutics to Participate in the Jefferies Healthcare Conference
June 01, 2023 07:15 ET
|
ADC Therapeutics SA
LAUSANNE, Switzerland, June 01, 2023 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that Ameet Mallik, Chief Executive Officer, will participate in a fireside chat at the...
International Myeloma Foundation to Host 2023 Global Myeloma Action Network (GMAN) Summit in Frankfurt
May 25, 2023 08:45 ET
|
International Myeloma Foundation
LOS ANGELES, May 25, 2023 (GLOBE NEWSWIRE) -- Founded in 2013 by the International Myeloma Foundation (IMF), the Global Myeloma Action Network (GMAN) will hold its Annual Summit in Frankfurt...
‘Crazy Guy on a Bike’ Andy Sninsky: Over 10 Years of Pedaling for Multiple Myeloma and Bringing Hope
May 18, 2023 05:45 ET
|
International Myeloma Foundation
LOS ANGELES, May 18, 2023 (GLOBE NEWSWIRE) -- Diagnosed in 2008 at age 59 with multiple myeloma, Andy Sninsky continues to be a formidable inertia in motion and a perpetual source of inspiration for...
Global Blood Cancer Diagnostics Market Size To Worth USD 16.27 Billion By 2030 | CAGR of 6.7%; Spherical Insights & Consulting
May 17, 2023 06:45 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , May 17, 2023 (GLOBE NEWSWIRE) -- The Global Blood Cancer Diagnostics Market Size to grow from USD 15.56 billion in 2021 to USD 16.27 billion by 2030, at a Compound Annual...
The Annual Czerkies Memorial Golf Outing: 15 Years of Helping the International Myeloma Foundation (IMF) Find a Cure for Multiple Myeloma
May 16, 2023 05:45 ET
|
International Myeloma Foundation
A Media Snippet accompanying this announcement is available by clicking on the image or link below: LOS ANGELES, May 16, 2023 (GLOBE NEWSWIRE) -- Now on its 15th year, the Annual Czerkies...
Vor Bio Reports First Quarter 2023 Financial Results and Provides Company Update
May 11, 2023 16:05 ET
|
Vor Biopharma
VBP101 clinical data update planned at European Hematology Association (EHA) 2023VCAR33ALLO IND submission on-track for 1H 2023 CAMBRIDGE, Mass., May 11, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq:...